Suscribirse

Association Between Cinnamon Consumption and Risk of Cardiovascular Health: A Systematic Review and Meta-Analysis - 15/12/21

Doi : 10.1016/j.amjmed.2021.07.019 
Chayakrit Krittanawong, MD a, b, , Ameesh Isath, MD c, Claire Ziemba Scott, MD a, b, Zhen Wang, MD d, e, Scott Kaplin, MD f, Hani Jneid, MD a, b, Carl J. Lavie, MD g, Salim S. Virani, MD, PhD a, b
a The Michael E. DeBakey VA Medical Center, Houston, Texas 
b Section of Cardiology, Baylor College of Medicine, Houston, Texas 
c Department of Medicine, Mount Sinai Morningside and Mount Sinai West, Mount Sinai Heart, New York, NY 
d Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery 
e Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, Minn 
f Department of Cardiovascular Medicine, NYU Langone – Long Island, Mineola, NY 
g John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, La 

Requests for reprints should be addressed to Chayakrit Krittanawong, MD, Section of Cardiology, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030.Section of CardiologyBaylor College of Medicine1 Baylor PlazaHoustonTX77030

Abstract

Background

Cinnamon has been used as a traditional herbal medication for decades. Several studies have investigated cinnamon consumption and cardiovascular risk. So far, the evidence remains inconclusive. Thus, we aim to systematically review the currently available literature and quantify the evidence, if possible.

Methods

We systematically searched Ovid MEDLINE, Ovid Embase, Ovid Cochrane Database of Systematic Reviews, Scopus, and Web of Science from database inception in 1966 through December 2020. The exposure of interest was cinnamon consumption, the outcome was cardiovascular risk defined as hemoglobin A1C, low-density lipoprotein cholesterol (LDL-c), and high-density lipoprotein cholesterol (HDL-c). Two investigators independently reviewed the data. Conflicts were resolved through consensus. Random-effects meta-analyses were used.

Results

Of 23 studies (1070 subjects), the included studies were heterogeneous, generally of very poor quality. We found no difference in LDL-c levels in patients who consumed cinnamon vs those who did not, with a weighted mean difference (WMD) of 0.38 (confidence interval [CI], −6.07-6.83). We also found no difference in HDL-c between the 2 groups with WMD 0.40 (CI, −1.14-1.94). In addition, we found no statistical differences in hemoglobin A1C between the 2 groups with WMD of 0.0 (CI, −0.44-0.45).

Conclusions

Our meta-analysis suggests that there is no association between cinnamon consumption and differences in LDL-c, HDL-c, and hemoglobin A1C levels. Further randomized control trials studies using a robust design with long-term cinnamon consumption are needed to further investigate any potential effect.

El texto completo de este artículo está disponible en PDF.

Keywords : Cardiovascular health, Cinnamon consumption, Meta-analysis, Systematic review



 Funding: None.
 Conflicts of Interest: CK discloses the following relationships: Member of the American College of Cardiology Solution Set Oversight Committee, the American Heart Association Committee of the Council on Genomic and Precision Medicine, and the American College of Cardiology/American Heart Association Task Force on Performance Measures, The Lancet Digital Health (Advisory Board), European Heart Journal Digital Health (Editorial board), Journal of the American Heart Association (Editorial Board), Journal of the American College of Cardiology: Asia (Section Editor), and The Journal of Scientific Innovation in Medicine (Associate Editor). SSV discloses the following relationships: Grant support: Department of Veterans Affairs, World Heart Federation, Tahir and Jooma Family Honorarium: American College of Cardiology (Associate Editor for Innovations, ACC.org) Steering Committee: Patient and Provider Assessment of Lipid Management (PALM) registry at Duke Clinical Research Institute (no financial remuneration). All other authors have no disclosures.
 Authorship: All authors had access to the data and a role in writing the manuscript. CK: conceptualization, methodology, data extraction, software, analysis writing – original draft preparation; AI: data extraction, data curation software; investigation; CZS: writing – reviewing and editing; ZW: methodology, data extraction, software, analysis; SK: writing – reviewing and editing, validation; HJ: writing – reviewing and editing; CJL: writing – reviewing and editing; SSV: writing – reviewing and editing.


© 2021  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 135 - N° 1

P. 110-117 - janvier 2022 Regresar al número
Artículo precedente Artículo precedente
  • Bilateral Paramedian Thalamic Infarct
  • Toshimasa Yamaguchi, Yosuke Yakushiji
| Artículo siguiente Artículo siguiente
  • Why Internal Medicine Program Directors Remain in Their Positions and Are Effective and Thrive: A Qualitative Study
  • Emily A. Stewart, Michael Kisielewski, Kathlyn Fletcher, Gretchen Diemer, Susan Lane, Abby Spencer, Lisa L. Willett

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.